2000
DOI: 10.1053/meta.2000.6739
|View full text |Cite
|
Sign up to set email alerts
|

Long-term administration of highly purified eicosapentaenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in male WBN/Kob rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0

Year Published

2002
2002
2010
2010

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 36 publications
(22 citation statements)
references
References 0 publications
1
21
0
Order By: Relevance
“…These results indicate that EPA-E inhibits ADP-or collageninduced platelet aggregation by causing an increase in platelet membrane fluidity. The above-mentioned results coincided with our previous data obtained in WBN/Kob rats treated with EPA-E [10]. In contrast, it became evident that lard, increasing the insulin resistance in OLETF rats, did not increase or decrease the above-mentioned parameters in this study.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…These results indicate that EPA-E inhibits ADP-or collageninduced platelet aggregation by causing an increase in platelet membrane fluidity. The above-mentioned results coincided with our previous data obtained in WBN/Kob rats treated with EPA-E [10]. In contrast, it became evident that lard, increasing the insulin resistance in OLETF rats, did not increase or decrease the above-mentioned parameters in this study.…”
Section: Discussionsupporting
confidence: 93%
“…Recently, we demonstrated that the long-term administration of EPA-E improves hyperglycemia, insulin resistance, and blood coagulation abnormalities in WBN/Kob rats, a model of spontaneous diabetes mellitus [10]. In the present study, we investigated whether the longterm treatment of EPA-E would ameliorate blood coagulation abnormalities and dysfunction of vascular endothelial and cells in OLETF rats, a model of spontaneous non-insulin-dependent diabetes mellitus with obesity.…”
Section: Discussionmentioning
confidence: 89%
“…Metformin, a biguanide, is known to improve insulin resistance in the clinical setting (11), and inhibition of fatty liver is believed to play a role in this (28,29). Polyunsaturated fatty acids have been reported to prevent fatty liver and to improve insulin resistance (30,31) via several mechanisms, including inhibition of the expression of lipogenic enzymes (32) by hindering binding of LXR to LXRE (33) to inhibit transcription of SREBP-1, and decrease in the content of triglycerides in the liver by enhancement of beta-oxidation of fatty acids through activation of PPARα (34). The suppression of expression of SREBP-1 by atorvastatin observed in this study suggests the possibility that atorvastatin decreases fat synthesis by decreasing the activity of lipogenic enzymes including FAS.…”
Section: Discussionmentioning
confidence: 99%
“…This difference between the two diets might have been due to the higher presence in HFD2 of precursors for ω3 polyunsaturated fatty acid (i.e. α-linolenic acid), which are known to protect from insulin resistance (Nobukata et al, 2000;Carpentier et al, 2006). At any rate, the different time-course of hyperglycemia with HFD1 and HFD2 allowed us to correlate some of the effects observed with the two diets on EC levels to the development of hyperglycemia or obesity.…”
Section: Composition Of the Hfdsmentioning
confidence: 99%